These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15687940)

  • 1. [Present and potential uses of mifepristone in gynecology, obstetrics and other medical specialties].
    Weingertner AS; Hamid D; Baldauf JJ; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 2004 Dec; 33(8):692-702. PubMed ID: 15687940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mifepristone--a new antiprogesterone in obstetrics and gynecology].
    Aschkenazi S; Levy T; Ben-Rafael Z
    Harefuah; 2001 May; 140(5):429-34. PubMed ID: 11419069
    [No Abstract]   [Full Text] [Related]  

  • 3. Mifepristone: contraceptive and non-contraceptive uses.
    Ho PC; Yu Ng EH; Tang OS
    Curr Opin Obstet Gynecol; 2002 Jun; 14(3):325-30. PubMed ID: 12032390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mifepristone (RU486): a review.
    Mahajan DK; London SN
    Fertil Steril; 1997 Dec; 68(6):967-76. PubMed ID: 9418681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [National symposium on clinical application of mifepristone in obstetrics and gynecology].
    Jiang M; Weng L; Wu Y; Wu S
    Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):265-7. PubMed ID: 11326929
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical application of mifepristone in obstetrics and gynecology].
    Weng L
    Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):261-4. PubMed ID: 11326928
    [No Abstract]   [Full Text] [Related]  

  • 7. Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties.
    Sun Y; Fang M; Davies H; Hu Z
    Gynecol Endocrinol; 2014 Mar; 30(3):169-73. PubMed ID: 24205903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone (RU 486): current knowledge and future prospects.
    Goldberg JR; Plescia MG; Anastasio GD
    Arch Fam Med; 1998; 7(3):219-22. PubMed ID: 9596454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of the antiprogestins.
    Kettel LM
    Clin Obstet Gynecol; 1995 Dec; 38(4):921-34. PubMed ID: 8616987
    [No Abstract]   [Full Text] [Related]  

  • 10. Mifepristone: bioavailability, pharmacokinetics and use-effectiveness.
    Sarkar NN
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):113-20. PubMed ID: 11858883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RU 486 (mifepristone). A short overview of its mechanisms of action and clinical uses at the end of 1996.
    Baulieu EE
    Ann N Y Acad Sci; 1997 Sep; 828():47-58. PubMed ID: 9329823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency contraception in a travel context.
    Glasier A
    J Travel Med; 1999 Mar; 6(1):1-2. PubMed ID: 10071364
    [No Abstract]   [Full Text] [Related]  

  • 13. Mifepristone: treatment of Cushing's syndrome.
    Sartor O; Cutler GB
    Clin Obstet Gynecol; 1996 Jun; 39(2):506-10. PubMed ID: 8734015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RU486 (mifepristone): mechanisms of action and clinical uses.
    Cadepond F; Ulmann A; Baulieu EE
    Annu Rev Med; 1997; 48():129-56. PubMed ID: 9046951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia.
    Newfield RS; Spitz IM; Isacson C; New MI
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):399-404. PubMed ID: 11298094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of anti-progesterones as a medical IUD.
    Nieman LK; Loriaux DL
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mifepristone (RU-486), from hell to purgatory].
    Botella Llusiá J
    An R Acad Nac Med (Madr); 1999; 116(1):21-34; discussion 34-8. PubMed ID: 10554390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple usages for antiprogestins].
    Heikinheimo O
    Duodecim; 1994; 110(10):1001-8. PubMed ID: 7588093
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel approach to human fertility control: contragestion by the anti-progesterone RU 486.
    Baulieu EE
    Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):125-9. PubMed ID: 3402651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mifepristone: pharmacology and clinical impact in reproductive medicine, endocrinology and oncology.
    Im A; Appleman LJ
    Expert Opin Pharmacother; 2010 Feb; 11(3):481-8. PubMed ID: 20102310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.